Head to Head Contrast: Viemed Healthcare (NASDAQ:VMD) vs. Basel Medical Group (NASDAQ:BMGL)

Basel Medical Group (NASDAQ:BMGL) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings.

Profitability

This table compares Basel Medical Group and Viemed Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Viemed Healthcare	4.81%	10.16%	7.22%

Risk & Volatility

Basel Medical Group has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500.

Valuation and Earnings

This table compares Basel Medical Group and Viemed Healthcare”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90 million	0.84	-$9.50 million	N/A	N/A
Viemed Healthcare	$270.28 million	1.28	$14.93 million	$0.36	25.22

Viemed Healthcare has higher revenue and earnings than Basel Medical Group.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Basel Medical Group and Viemed Healthcare, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1	0	0	0	1.00
Viemed Healthcare	0	3	1	0	2.25

Viemed Healthcare has a consensus price target of $14.00, indicating a potential upside of 54.19%. Given Viemed Healthcare’s stronger consensus rating and higher probable upside, analysts clearly believe Viemed Healthcare is more favorable than Basel Medical Group.

Institutional and Insider Ownership

74.2% of Viemed Healthcare shares are owned by institutional investors. 20.6% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Viemed Healthcare beats Basel Medical Group on 12 of the 12 factors compared between the two stocks.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

About Viemed Healthcare

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.